Conygar Investment (CIC) Share Price, News & Analysis

Company Overview

The Conygar Investment Company PLC ("the Company") is incorporated in the United Kingdom and domiciled in England and Wales, is registered at Companies House under registration number 04907617, listed on the AIM market of the London Stock Exchange and limited by shares. The financial information set out in this report covers the six months to 31 March 2023, with comparative amounts shown for the six months to 31 March 2022 and the year to 30 September 2022, and includes the results and net assets of the Company and its subsidiaries, together referred to as the Group.

Key Stats

• Today's Range: 40 to 43
• 50-Day Range: 40.55 to 59
• 52-Week Range: 40 to 94
• Volume: 121,236 shs
• Average Volume: 49,499 shs
• Market Capitalization: £25.02 million
• P/E Ratio: N/A
• Dividend Yield: 4.77%
• Price Target: N/A
• Consensus Rating: N/A

CIC Stock Analysis - Frequently Asked Questions

How have CIC shares performed this year?

Conygar Investment's stock was trading at GBX 43.40 on January 1st, 2025. Since then, CIC shares have decreased by 3.3% and is now trading at GBX 41.95.
View the best growth stocks for 2025 here.

How were Conygar Investment's earnings last quarter?

The Conygar Investment Company PLC (LON:CIC) posted its quarterly earnings data on Tuesday, December, 17th. The company reported ($56.46) earnings per share (EPS) for the quarter.

How do I buy shares of Conygar Investment?

Shares of CIC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Conygar Investment own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Conygar Investment investors own include B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Greencore Group (GNC), IQE (IQE) and Omega Diagnostics Group (ODX).

Company Calendar

• Last Earnings: 12/17/2024
• Today: 2/01/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Real Estate
• Industry: Real Estate - Development
• Sub-Industry: N/A
• Current Symbol: LON:CIC
• CUSIP: N/A
• CIK: N/A
• Web: www.conygar.com
• Phone: +44-20-72588670
• Fax: N/A
• Employees: 111
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.52)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £-31,090,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -29.12%
• Return on Assets: -5.03%

Debt

• Debt-to-Equity Ratio: 44.71
• Current Ratio: 3.16
• Quick Ratio: 11.14

Sales & Book Value

• Annual Sales: £4.92 million
• Price / Sales: 5.09
• Cash Flow: GBX 9.04 per share
• Price / Cash Flow: 4.64
• Book Value: GBX 153 per share
• Price / Book: 0.27

Miscellaneous

• Outstanding Shares: 59,640,000
• Free Float: N/A
• Market Cap: £25.02 million
• Optionable: Not Optionable
• Beta: 0.51